Publication

Article

BioPharm International

BioPharm International-08-01-2002
Volume15
Issue 8

Inside Washington: User Fee Program Seeks to Spur Biotech Development

Author(s):

PDUFA III boost manufacturer fees to cover postapproval surveillance and streamline the FDA review process

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
© 2025 MJH Life Sciences

All rights reserved.